NCT03984721View on ClinicalTrials.gov

Amyloidosis Typing Using Mass Spectrometry-based Proteomics: a New Accurate Tool for Difficult Typing

NACompletedINTERVENTIONAL
Enrollment

27

Participants

Timeline

Start Date

July 25, 2019

Primary Completion Date

September 8, 2021

Study Completion Date

September 8, 2021

Conditions
Amyloidosis
Interventions
DIAGNOSTIC_TEST

Amyloidosis typing using mass spectrometry-based proteomics

Amyloidosis typing using nanoLC-MS/MS method

Trial Locations (1)

31059

University hospital of Toulouse, Toulouse

All Listed Sponsors
collaborator

Centre National de la Recherche Scientifique, France

OTHER

lead

University Hospital, Toulouse

OTHER

NCT03984721 - Amyloidosis Typing Using Mass Spectrometry-based Proteomics: a New Accurate Tool for Difficult Typing | Biotech Hunter | Biotech Hunter